Get Brochure

SERVICES

Regulatory Services in Vietnam

Regulatory Compliance Experts in Vietnam

The Ministry of Health (MoH) is responsible for overseeing all regulatory activities for pharmaceutical products including medicines, biologicals, and medical devices. The divisions that fall under the MoH includes the Drug Administration of Vietnam (DAV) that oversees pharmaceuticals, and the Department of Medical Equipment and Construction (DMEC) which monitors medical devices activities. The Department of Pharmaceutical Management (DPM) is responsible for ensuring that Good Manufacturing Practices (GMP) are implemented and adhered to the WHO’s GMP standards. This increases pharmaceutical product export opportunities as most countries accept globally renowned GMP standards.

In order to obtain marketing authorization for a drug, pharmaceutical manufacturers must obtain either a drug manufacturing or drug trading license from the DAV. However, only Vietnamese-based entities can obtain a license. Foreign companies that wish to seek marketing authorization for their products in Vietnam are more likely to succeed by partnering with an entity that has experience in the Vietnamese pharmaceutical regulatory sector.

As a leading global contender, DDReg’s regulatory services in Vietnam provide ongoing support and development of customized strategies during all regulatory phases while keeping track of the most recent regulatory requirements to ensure high-quality and timely submissions. We deliver reliable safety measures, ensure risk mitigation, and collaborate with experts to facilitate effortless delivery of product launches, regulatory filings, and market authorizations.

Our Regulatory Consulting Services In Vietnam Portfolio Covers

  • Regulatory Strategies and Expert Views
  • Regulatory Due Diligence
  • Gap Analysis and Remediation
  • New Product Authorizations
  • Post Approval Life Cycle Management
  • CMC Advisory
  • API -DMF

    Our Regulatory Affairs Consulting Services in Vietnam portfolio covers:

    Strategies

    Regulatory Strategies / Expert Views

    Regulations pertaining to pharmaceutical products are continuously changing...

    Read More ➔
    Authorizations

    New Product Authorizations

    Pharmaceuticals and other medicinal products need to be prior authorized by...

    Read More ➔
    Analysis

    Gap Analysis and Remediation

    A gap analysis is a regulatory review process that identifies data gaps in the technical...

    Read More ➔
    delig

    Regulatory Due Diligence

    Regulatory issues arise unexpectedly and can create significant strain on a company’s...

    Read More ➔
    Authorizations

    API/DMF

    DDReg provides expert consulting and efficient services for quality Drug Substance...

    Read More ➔
    CMC

    CMC Advisory

    When it comes to regulatory strategies, CMC documentation play a crucial role in developing...

    Read More ➔
    Approval

    Post Approval Life Cycle Management

    Managing the post-approval life cycle of a product is an essential component to sustaining...

    Read More ➔
    Regulatory Certification

    Regulatory Certification

    Administrative documents are an integral component of regulatory submissions and constitute key certifications...

    Read More ➔
    Regulatory Certification

    ANDA and MA Holder Services

    The regulatory approval pathway for Abbreviated New Drug Applications (ANDAs) is relatively complex....

    Read More ➔
    Contact our experts today !
    Country Specific Services

    How can we help you?
    Call us on:+1 (302) 601-2755